Facilitated By

San Antonio Medical Foundation

News

  • 1 in 4 ABC patients treated with Novartis Kisqali remain progression-free beyond 4 years

    A fully integrated, R&D-driven biotechnology company listed on the Hong Kong Stock Exchange (1672.HK). ... biotech entity) and Shaoxing ...

  • AI-Powered Deep Proteomics Enables Early, Non-Imaging Detection of Breast Cancer With ...

    At the San Antonio Breast Cancer Symposium (SABCS) in San Antonio ... Bioscience's Certitude Breast test, a breakthrough, AI-powered proteomics ...

  • BriaCell Presents Outstanding Phase 2 Survival & Promising Phase 3 Clinical Data at SABCS® 2025

    ... San Antonio Breast Cancer Symposium taking place December 9-12, 2025 at ... When it comes to biotech ETFs, they give sector participants exposure to ...

  • Biomea Fusion Announces KOL Presentation and Interview on Menin and Icovamenib at ...

    ... San Antonio. The interview highlights the growing body of preclinical ... astr<60 is a webinar series created by astr partners for biotech and finance ...

  • Dean Kamen-founded ARMI to complete biomanufacturing center by 2027 - Boston Business Journal

    San Antonio · San Francisco · Seattle · Silicon Valley · St. Louis · Tampa Bay ... Biotech says therapy helps patients keep weight off post-GLP-1.